Personal profile
Biography
Victoria joined the Cancer Research UK Clinical Trials Unit (CRCTU) after completing the MSc Medical Statistics at the University of Leicester and is now a senior statistician within the unit. She is involved in the design, supervision, analysis and reporting of clinical trials in a variety of oncology and non-oncology clinical areas in both adult and paediatric populations. She has experience in all phases of trial from first-in-human and dose finding trials to randomised phase III trials of investigational medicinal products, devices, and advanced and cellular therapies.
Victoria’s work focuses on early phase dose finding and proof of activity clinical trials, Bayesian methodology, and trials in rare diseases. She has a keen interest in improving efficiency in trials, mainly through adaptive designs, novel dose finding methods, and hierarchical and repeated measures analysis.
Moreover, Victoria is the deputy director of the MRC-NIHR UK Rare Disease Research Platform CAPTIVATE node for trials methodology in rare diseases. This challenge node is aiming to develop innovative clinical trial designs that enable the efficient evaluation of treatments for rare diseases with limited numbers of participants such that the designs and data are acceptable to patients and participants, regulators, and policy makers.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Defining Puberty and Spectrum of Hypogonadism in Alström Syndrome
Ali, S., Zhang, Q., Anwunah, I., Baig, S., da Silva Xavier, G., Dawson, C., Dassie, F., Tang, Y., Wang, L., Chang, G., Gleeson, P., Warfield, A. T., Paisey, R., Barrett, T. G., Maffei, P., Wang, X., Homer, V., Kershaw, M. & Geberhiwot, T., Jan 2026, In: Journal of Clinical Endocrinology and Metabolism. 111, 1, p. 33-44 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol
Fisher, B. A., Rowe, A., Hodson, C., Wilkhu, M., Williams, E., Turner, E., Allard, A., Blake, T., Bombardieri, M., Cope, A. P., Dubey, S., Mankia, K., Malley, T., Moore, O., Payne, M., Plummer, R., Tilby, M., Tillett, T., Wong, E. & Wu, Y. & 4 others, , 3 Mar 2026, In: BMJ Open. 16, 3, 10 p., e116847.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Procedures of data merging in precision cancer medicine: the PRIME-ROSE project
van der Pol, H., Kringelbach, T., Agudo, M. M., Stav, G. B., Fagereng, G. L., Fiocco, M., Falk, R. S., Homer, V., Mohammad, S. H., Timmer, H., Verlingue, L., Helland, Å., Rohrberg, K., Lassen, U., Halford, S., Jalkanen, K., Juslin, T., Krebs, M. G., Oliveira, J. & Baltruškevičienė, E. & 4 others, , 6 Jan 2026, In: Acta Oncologica. 65, p. 1-8 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Downloads (Pure) -
Efficacy and optimal dose of acetic acid for treating colonised burns wounds (AceticA): a double-blind, single Centre, randomised, controlled phase II trial
Moiemen, N., Homer, V., Nice, L., Brock, K., Jenkins, S., Altarrah, K., Imran, R., Tullie, S., Barton, D. & Lax, S. (Contributor), 18 Dec 2025, (E-pub ahead of print) In: Journal of Burn Care and Research. 10 p., iraf228.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Downloads (Pure) -
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
Al-Shakhshir, S., Quraishi, M. N., Mullish, B., Patel, A., Vince, A., Rowe, A., Homer, V., Jackson, N., Gyimah, D., Shabir, S., Manzoor, S., Cooney, R., Alrubaiy, L., Quince, C., van Schaik, W., Hares, M. F., Beggs, A. D., Efstathiou, E., Rimmer, P. & Weston, C. & 2 others, , 6 Jan 2025, In: BMJ Open. 15, 1, 11 p., e095392.Research output: Contribution to journal › Article › peer-review
Open AccessFile65 Downloads (Pure)
-
NIHR168620 - HALT-colitis - Does the addition of FMT to standard treatment in newly diagnosed mild to moderate ulcerative colitis reduce the need for therapy escalation
Rowe, A. (Co-Investigator), Iqbal, T. (Principal Investigator), Iqbal, A. J. (Co-Investigator), Retzer, A. (Co-Investigator), Beggs, A. (Co-Investigator), McGettrick, H. (Co-Investigator), Homer, V. (Co-Investigator) & McMullan, C. (Co-Investigator)
1/02/26 → 31/01/31
Project: Other Government Departments
-
LifeArc Translational Rare Disease Centre RD-TAP
Calvert, M. (Co-Investigator), Blackburn, S. (Co-Investigator), Billingham, L. (Co-Investigator), Harper, L. (Co-Investigator), Kearns, P. (Co-Investigator), Gates, S. (Co-Investigator), Aiyegbusi, L. (Co-Investigator), Trivedi, P. (Co-Investigator), Gkoutos, G. (Co-Investigator), Homer, V. (Co-Investigator), Barrett, T. (Principal Investigator), Retzer, A. (Co-Investigator) & Higgs, M. (Co-Investigator)
1/09/24 → 31/08/29
Project: Research
-
Remission induction of arthritis caused by cancer immunotherapy [REACT]: a randomised multicentre trial to guide initial therapy for checkpoint inhibitor [CPI] induced arthritis
Rowe, A. (Co-Investigator), Filer, A. (Co-Investigator), Homer, V. (Co-Investigator) & Fisher, B. (Principal Investigator)
1/09/23 → 31/08/28
Project: Other Government Departments
-
Changing clinical practice in rare diseases through innovative trial designs: the CAPTIVATE node
Barrett, T. (Co-Investigator), Homer, V. (Co-Investigator), Gates, S. (Co-Investigator), Kearns, P. (Co-Investigator) & Billingham, L. (Principal Investigator)
3/07/23 → 2/07/28
Project: Research Councils
-
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Rowe, A. (Co-Investigator), Slade, D. (Co-Investigator), Gates, S. (Co-Investigator), Curbishley, S. (Researcher) & Homer, V. (Principal Investigator)
1/11/21 → 30/04/29
Project: Research Councils